Cargando…
The Development of Three-DNA Methylation Signature as a Novel Prognostic Biomarker in Patients with Colorectal Cancer
AIMS: The prognosis of colorectal cancer (CRC) remains poor. This study aimed to develop and validate DNA methylation-based signature model to predict overall survival of CRC patients. METHODS: The methylation array data of CRC patients were retrieved from The Cancer Genome Atlas (TCGA) database. Th...
Autores principales: | Gong, Shu, Ye, Weijian, Liu, Tiankai, Jian, Shaofen, Liu, Wenhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714567/ https://www.ncbi.nlm.nih.gov/pubmed/33294438 http://dx.doi.org/10.1155/2020/3497810 |
Ejemplares similares
-
Functional Expression, Purification and Identification of Interaction Partners of PACRG
por: Liu, Tiankai, et al.
Publicado: (2021) -
A 3-DNA methylation signature as a novel prognostic biomarker in patients with sarcoma by bioinformatics analysis
por: Wang, Xiao-Wei, et al.
Publicado: (2021) -
Prognostic and Predictive Value of Three DNA Methylation Signatures in Lung Adenocarcinoma
por: Wang, Yanfang, et al.
Publicado: (2019) -
A four-DNA methylation signature as a novel prognostic biomarker for survival of patients with gastric cancer
por: Li, Chunmei, et al.
Publicado: (2020) -
Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression
por: Muthamilselvan, Sangeetha, et al.
Publicado: (2022)